Drugs / PBMSCs
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT03766139 | Dec 2018 → Jun 2019 | periodontal disorder | KLE Society's Institute of Dental Sciences | Unknown | No outcome recorded |
| Phase 11 trial | ||||||
| Phase 1 | NCT03044119 | Mar 2018 → Jul 2019 | — | KLE Society's Institute of Dental Sciences | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PBMSCs | “It will be very convenient if peripheral blood mesenchymal stem cells (PBMSCs) could be harvested and expanded to enough numbers, with their osteogenic capacity maintained in a...” NCT03766139 ↗ |
| Known as | peripheral blood mesenchymal stem cells | “It will be very convenient if peripheral blood mesenchymal stem cells (PBMSCs) could be harvested and expanded to enough numbers, with their osteogenic capacity maintained in a...” NCT03766139 ↗1“peripheral blood mesenchymal stem cells (PBMSCs) could be harvested and expanded to enough numbers, with their osteogenic capacity maintained in a clinical permitted period.” NCT03044119 ↗ |
| Modality | Cell therapy | “peripheral blood mesenchymal stem cells which are the biological materials procured from patient's peripheral blood” NCT03044119 ↗ |